Strategic Partner for Medical Professionals, PT Medela Potentia Tbk Subsidiary Brings Cutting-Edge Innovation at KONAS & PIT PDS Patklin 2025

As a strategic partner for medical professionals in Indonesia, PT Medela Potentia tbk subsidiary PT Djembatan Dua continues to advance healthcare diagnostics by bringing cutting-edge technologies that align with modern clinical practices. This commitment was once again demonstrated through the company’s participation in the 12th National Congress (KONAS) and 24th Annual Scientific Meeting (PIT) of the Indonesian Association of Clinical Pathology and Laboratory Medicine Specialists (PDS Patklin), held on October 22–24, 2025, in Medan.

As part of the event, PT Djembatan Dua supported the Workshop on Bone Marrow Puncture Procedure, attended by 42 participants, comprising Clinical Pathology specialists at the Faculty of Medicine, Universitas Sumatera Utara (FK USU), on Wednesday, October 22, 2025. During the session, the company introduced its Vigeo product portfolio, designed for bone marrow aspiration and biopsy procedures.

Vigeo is a single-use bone marrow aspiration and biopsy needle solution that offers a more efficient, safe, and modern user experience. Engineered with high precision, Vigeo facilitates easier sample collection, minimizes cross-contamination risks, and enhances both patient comfort and safety. This innovation reinforces PT Djembatan Dua’s commitment to delivering medical technologies that meet global patient safety standards.

“We strive to ensure that medical professionals have access to more efficient and safer medical technologies. Our products are designed to support high-quality clinical practice while prioritizing user convenience,” said Mrs. Ariance Margaretha, Business Manager of PT Djembatan Dua.

By providing hands-on experience with Vigeo during the practical session, PT Djembatan Dua aims to raise awareness and strengthen healthcare professionals’ confidence in the quality of its products. This participation also marks a strategic step for the company in solidifying its position as a trusted partner in providing high-quality medical devices for the field of clinical pathology.

Through national scientific forums such as KONAS XII and PIT XXIV PDS Patklin 2025, PT Djembatan Dua continues to demonstrate its dedication to delivering innovative and relevant medical technologies that support the advancement of excellence in healthcare services across Indonesia.